Structural basis for activation of a diguanylate cyclase required for bacterial predation in Bdellovibrio by Meek, Richard W. et al.
 
 
Structural basis for activation of a diguanylate
cyclase required for bacterial predation in
Bdellovibrio
Meek, Richard W.; Cadby, Ian T.; Moynihan, Patrick J.; Lovering, Andrew L.
DOI:
10.1038/s41467-019-12051-6
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Meek, RW, Cadby, IT, Moynihan, PJ & Lovering, AL 2019, 'Structural basis for activation of a diguanylate
cyclase required for bacterial predation in Bdellovibrio', Nature Communications, vol. 10, no. 1, 4086 .
https://doi.org/10.1038/s41467-019-12051-6
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 17/09/2019
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 22. Oct. 2019
ARTICLE
Structural basis for activation of a diguanylate
cyclase required for bacterial predation in
Bdellovibrio
Richard W. Meek1, Ian T. Cadby 1, Patrick J. Moynihan 1 & Andrew L. Lovering 1
The bacterial second messenger cyclic-di-GMP is a widespread, prominent effector of life-
style change. An example of this occurs in the predatory bacterium Bdellovibrio bacteriovorus,
which cycles between free-living and intraperiplasmic phases after entering (and killing)
another bacterium. The initiation of prey invasion is governed by DgcB (GGDEF enzyme) that
produces cyclic-di-GMP in response to an unknown stimulus. Here, we report the structure of
DgcB, and demonstrate that the GGDEF and sensory forkhead-associated (FHA) domains
form an asymmetric dimer. Our structures indicate that the FHA domain is a consensus
phosphopeptide sensor, and that the ligand for activation is surprisingly derived from the N-
terminal region of DgcB itself. We conﬁrm this hypothesis by determining the structure of a
FHA:phosphopeptide complex, from which we design a constitutively-active mutant (con-
ﬁrmed via enzyme assays). Our results provide an understanding of the stimulus driving
DgcB-mediated prey invasion and detail a unique mechanism of GGDEF enzyme regulation.
https://doi.org/10.1038/s41467-019-12051-6 OPEN
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The switch between distinct lifestyle states in bacteria (e.g.motile to sessile, bioﬁlm to planktonic) is often co-ordinated by the ubiquitous second messenger cyclic-di-
GMP (c-di-GMP)1. Therein, sensory subdomains (commonly
receptors for small molecules, or domains gated by protein:pro-
tein interaction) control the activity of c-di-GMP production and
degradation by appending these to GGDEF and EAL/HD-GYP
enzymatic domains, respectively—all three enzymes named after
active site motifs. Free c-di-GMP is sensed by a variety of
recognition modules, e.g., PilZ domains2, riboswitches3, non-
catalytic GGDEF/EAL variants4, and coupled to downstream
outputs that effect the lifestyle switching. Different lifestyles
require varying pathway complexity—one such bacterium with a
high c-di-GMP “intelligence” is the bacterial predator Bdellovibrio
bacteriovorus, encoding 5 GGDEF synthases (one degenerate), 1
EAL and 6 HD-GYP hydrolases (4 degenerate), and >18 PilZ
receptors in the model strain HD100 (ref. 5). This network
complexity may run to even greater depths, with an additional 65
putative novel receptors identiﬁed using c-di-GMP resin afﬁnity
methods6. This need for multiple, diverse signaling pathways is
presumably related to the diverse environments encountered
during the Bdellovibrio lifecycle.
B. bacteriovorus is an obligate bacterial predator of other
Gram-negative bacteria, exploiting adaptations that allow con-
sumption from inside the prey cell periplasm7. Access to this
“private dining niche” is afforded by a staged invasion process
requiring (i) a free-living phase where the predator swims and/or
glides to locate prey; (ii) an initially reversible attachment event
that proceeds to a tight junction between both cells; (iii) whole-
cell outer-membrane invasion, in which the predator pulls itself
into the prey periplasm using a type IV pilus; and (iv) resealing of
the invasion pore. The invaded cell is stabilized and modiﬁed to
become what is referred to as the bdelloplast, prior to metabolism
and assimilation of prey macromolecules by Bdellovibrio. The
ﬁlamentous predator then grows and septates, releasing progeny
via lysis of the host cell. Landmark studies revealed discrete
phenotypes for Bdellovibrio GGDEF gene knockouts, and that
each GGDEF could not compensate for loss of another8. The four
GGDEFs shown to be active (linking two molecules of GTP to
give the c-di-GMP product) were given the preﬁx Dgc (Digua-
nylate cyclases) A-D, and the remaining degenerate variant
GGDEF was found to be a receptor (CdgA). The varied pheno-
types tallied with lifecycle events, with loss of DgcA preventing
exit from the exhausted prey shell, and loss of CdgA resulting in
slower invasion than wild-type cells. Intriguingly, loss of DgcB
and DgcC gave rise to opposing effects—the ΔDgcB predator
unable to commit to prey invasion (resulting in obligate axenic
growth), and the ΔDgcC predator unable to convert to a form
able to grow outside prey (host-independent stage, licensed in the
lab via mutation). ΔDgcD cells had no gross observable deﬁcit
and require further investigation to ascertain any functional
importance. Hence, it was hypothesized that lack of natural
complementation between Dgc knockouts resulted from either
local circuits of c-di-GMP (resulting in a signal not freely diffu-
sible) or a requirement for the Dgc proteins to be physically
present at a cellular site. An example of such a system has been
observed in other bacteria, e.g. Pseudomonas ﬂuorescens, where c-
di-GMP has been shown to bind to an inhibitory (I-site, RxxD
motif) region of the GGDEF fold, turning the resulting protein:
nucleotide complex into a unique signaling agent9.
Control of initiation of the B. bacteriovorus predation lifecycle
may thus involve the opposing effects of DgcB and DgcC, with
invasion gated by prey-contact/encounter-stimulated activation
of DgcB. Activated DgcB would then signal to CdgA, amongst
other targets. The ability to invade and kill prey (as monitored by
plaque formation on prey lawns) was demonstrated to be
dependent on active DgcB, given that the knockout could not be
complemented by a GGAAF non-catalytic variant8. The dgcB
gene, bd0742, has orthologues in other Bdellovibrio strains and
also distantly related myxococccal predators (that kill prey by an
entirely different “Wolfpack” mechanism)10. The DgcB protein
appends the C-terminal GGDEF enzymatic domain with an N-
terminal forkhead-associated (FHA) domain, known to be used
(in other proteins) for interactions with phosphopeptide ligands8.
The novel domain architecture of DgcB is interesting—were the
activity of DgcB to be dependent on classical FHA function/
principles, invasion could potentially involve a sensory kinase
that would respond to prey encounter by phosphorylating a
protein ligand which would then bind DgcB at the FHA domain
to regulate GGDEF activity and thus c-di-GMP production. We
reasoned that a structure of DgcB would inform on whether the
predicted N-terminal FHA domain was a bone-ﬁde signaling
domain with a consensus binding cleft, and whether its juxta-
position to the GGDEF domain was likely to render it inhibitory
or stimulatory.
To determine the precise mechanism behind DgcB activation,
with the aim of understanding the events that license switching of
Bdellovibrio into an invasion-competent diguanylate cyclase-
active state, we determined the structure of DgcB. Our structure
reveals a stimulatory role for the N-terminal tail of DgcB and we
show that the DgcB FHA domain recognizes this tail in its
phosphorylated state. In addition, we conﬁrm this mechanism of
activation by the use of disulﬁde mutagenesis to lock DgcB in an
obligate-activated state.
Results
DgcB structure determination. An initial full-length construct
yielded a 1.79 Å crystal structure (statistics for all structures are
provided in Table 1), composed of two copies in the asymmetric
unit. This structure was solved via molecular replacement using
isolated domains from GGDEF and FHA proteins, allowing the
majority of the polypeptide chain to be resolved (aa 32–134 and
144–310). DgcB comprised a ~30aa tail, 100aa FHA, 20aa linker
and 160aa GGDEF domain. Distance constraints guided the
assignment of FHA domains to their respective GGDEF partners,
revealing a unique conformation for each chain. This arrange-
ment is best described as a pseudosymmetrical GGDEF dimer,
appended to two FHA domains that are asymmetrically orien-
tated (Fig. 1a); the net effect is to place the FHA domains closer to
GGDEF chain B. The dimer is stabilized by two molecules of c-di-
GMP (classically intercalating via their planar bases), bound at
the I-site of both monomers (Fig. 1a, b). The bound c-di-GMP
arises from co-puriﬁcation, as a result of (basally) active DgcB.
The resulting (FHA:GGDEF:c-di-GMP)2 DgcB complex has
approximate dimensions of 70 × 70 × 40 Å. The overall DgcB
architecture and topology is unique among determined structures
but the individual domains are in good agreement with char-
acterized domains from other proteins. DALI analysis11 of
structural similarity results in high conﬁdence matches of DgcB
with the GGDEF domain of PleD (2V0N12, Z-score 26.3, 35%
identity, RMSD 1.3 Å for 162aa alignment) and the FHA domain
of GarA (2XT9, Z-score 18.5, 34% identity, RMSD 0.9 Å for 93aa
alignment), among many other signiﬁcant pairwise agreements.
The DgcB FHA domain has a consensus structure. DgcB retains
the archetypal ~100aa 11-stranded β-sandwich topology of the
FHA superfamily (6-stranded antiparallel sheet, 5-stranded mixed
sheet), used by varying proteins to interact with pThr containing
peptides. FHA domains are usually compact, recognizing a linear
phosphopeptide substrate in their binding partner, e.g. the FHA
domain of Rad53p forms a complex with a phosphopeptide from
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Rad9p, and is used to regulate the cell cycle of yeast13. The FHA
domain of DgcB is relatively small in size (with no signiﬁcant
insertions into the loops between strands), resulting in a very
compact subdomain with “ﬂat” faces. Consistent with assignment
to the FHA superfamily, the DgcB sequence contains the con-
sensus residues that comprise the ligand-binding cleft, using S75,
R76 and T96 at the apical face of the FHA domain to create a
classical phosphopeptide recognition pocket14. The ﬂoor of this
pocket is stabilized by the buried H78 sidechain. Examination of
the pocket reveals that the putative phosphate site is occupied by
a bound ion in chain B, and that of chain A is partially occluded
by residue D56 (Fig. 1c). The D56 interaction between one FHA
domain and another sits at the centre of an interface that buries
582.4 Å2 surface area. The FHA:FHA interface is composed of
both hydrophobic and hydrophilic interactions, packing the
phosphopeptide binding surface/loops of chain A against one face
of the chain B β-sandwich. The vast majority of contacts to the
GGDEF dimer are made by the chain A FHA domain (Fig. 1d);
these comprises both polar (D70 and K48 to chain B) and non-
polar (I40 and I126 to chain A, Y45 and Y68 to chain B) inter-
actions. A putative N-terminal tail preceding the FHA domain
(residues 1–31) is present on our construct but presumed dis-
ordered in this structure.
Features of linker region and enzymatic GGDEF domain. The
interdomain region (residues 135–143 inclusive) is not discern-
able for either chain in the electron density map, needing to span
a distance of 14/19 Å for chains A/B, respectively. The remaining
linker polypeptide is in differing conformations between the two
monomers: chain A has a small helical region in the linker
(146–154, displaying density for the mainchain but weak density
for sidechains), and chain B has an extended conformation that
starts the ﬁrst GGDEF helix (α0, 157–172) one turn earlier than
chain A. The chain B arrangement is more comparable to other
determined GGDEF structures1,12, wherein the preceding con-
served DxLT motif (150–153) involved in enzyme activation is
present in a tight turn (in chain A this has a differing structure
and is part of the small helix). Other than the linker region, the
two GGDEF domains are very similar in structure, with the active
site motifs (sequence GGEEF, natural D to E variant) facing in
opposing directions (Fig. 1).
The bound c-di-GMP dimer at the DgcB I-site is orientated in
line with the two-fold axis of the GGDEF dimer (Fig. 1b),
complexed by R218 and D221 of the conserved RxxD motif.
Additional contacts to the c-di-GMP are made from residues
T242, V246 and R249 on the face of an α-helix. The sidechain of
R249 stacks with the guanine base, hydrogen bonding to the O
and N7 of the opposing c-di-GMP guanine and the carbonyl of
L216. This interaction appears to stabilize a helical turn that
precedes the RxxD motif into a π (I +5) conformation, and allow
the carbonyl of K215 to hydrogen bond to the c-di-GMP 2′-OH.
The interactions of DgcB with the c-di-GMP ligand provide the
major contact between the two GGDEF domains (Fig. 1b); direct
protein:protein contacts are limited to just one weak interaction
involving the partially ordered linker region.
A FHA-only structure suggests a self-stimulatory peptide. Our
“full-length” structure of DgcB did not reveal the conformation of
the N-terminal tail (residues 1–31), possibly as a result of being
locked in a c-di-GMP-inhibited state. To resolve this issue, we
obtained 1.87 Å data on a new crystal form (tail-FHA only,
lacking the GGDEF domain) comprised of residues 1–135 of
DgcB. In this new form, four FHA domains comprise the
asymmetric unit, with each monomer arranged at ~90˚ to the
neighboring domain. Upon imposing crystal symmetry, it is
apparent that each monomer contacts a symmetry-related
molecule in precisely the same manner as chains A and B of
the full-length DgcB structure (mediated through D56, Fig. 2a,
also Supplementary Fig. 1). Hence it can be inferred that the
FHA:FHA contacts in full-length DgcB are not dictated by con-
straints imposed by the GGDEF domain.
For one of the FHA domains, difference density was observable
at the putative phosphopeptide-binding cleft (next to consensus
residues S75, R76 and T96). Our high resolution data allowed us
to unambiguously model this density as residues K13-S19 of the
previously disordered N-terminal tail of DgcB. It was not possible
to assign the tail as originating from a speciﬁc chain (chain B, C
and D FHA domains are all close enough to span the distance to
the bound tail). In agreement with assignment of the FHA
domain as a putative phosphothreonine receptor, the interactions
between the tail and FHA cleft centre around residue T14, which
is conserved in homologues of DgcB (Fig. 2b). The FHA cleft
makes three hydrogen bonds to the tail (involving R61, T96 and
N97), which binds in a linear conformation across the apical face
of the FHA fold (Fig. 2a, c). Prior to this study, any potential
stimulus peptide substrate for DgcB was unknown—our observa-
tion that the FHA of DgcB could recognize a self peptide led us to
investigate sequence features and conservation at this region of
the protein. Aligning the N-terminal tail from a representative
group of DgcB homologues reveals a pattern of conservation
across a seven residue span (−3 to +3 with respect to the central
threonine); our structure underlines the importance of the +3
position (V17), which points downward into the cleft and is a
Table 1 Data collection and reﬁnement statistics
Full length FHA:tail FHA:
phosphopeptide
Accession code 6HBZ 6HC0 6HC1
Data collection
Space group P6522 P212121 P6522
Cell dimensions
a, b, c (Å) 176.8,
176.8, 112.1
69.4,
69.4, 129.0
68.8, 68.8, 191
α, β, γ (˚) 90, 90, 120 90, 90, 90 90, 90, 120
Resolution (Å) 1.79 (90.45)a 1.87 (36.53) 1.49 (56.84)
Rsym 0.120 (>1.0) 0.079 (>1.0) 0.129 (>1.0)
Rpim 0.028
(0.455)
0.033
(0.777)
0.030 (0.792)
I/σI 20.4 (2.6) 19.1 (1.4) 16.1 (1.2)
CC ½ 0.998
(0.448)
1.0 (0.617) 0.999 (0.545)
Completeness (%) 100 (99.6) 100 (100) 100 (100)
Redundancy 37 (36.9) 12.8 (12.6) 33.5 (24.2)
Reﬁnement
Resolution (Å) 1.79 1.87 1.49
No. of reﬂections 97426 52162 44616
Rwork/Rfree 17.9/21.6 17.7/20.6 14.2/17.8
No. of atoms
Protein 4192 3149 1656
Ligand/ion 113 3 —
Water 439 284 192
B-factors
Protein 35.74 41.95 26.37
Ligand/ion 32.48 37.92 —
Water 44.37 48.01 40.29
R.m.s. deviations
Bond lengths (Å) 0.011 0.017 0.016
Bond angles (°) 1.59 1.79 1.70
aValues in parentheses are for highest-resolution shell. Each dataset derives from a single
crystal
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crucial recognition feature of the peptide substrate in other FHA-
based sensory systems14.
The highest-conﬁdence matches (via DALI) of the DgcB FHA
are GarA and OdhI, which also utilize a self-peptide recognition
mode for signaling purposes (using steric occlusion to regulate
interaction with other proteins15,16). Comparison of the tail
region between DgcB and homologues suggests that similar
features are recognized between the two differing systems:
hydrophobic residues at the −3, +2 and +3 positions, glutamate
(DgcB E12) at −2 and serine (S15) at +1. Upon structural
superimposition of DgcB and OdhI via the FHA β-sandwich, it is
apparent that the phosphopeptide of the OdhI tail sits in a slightly
different position to the unphosphorylated tail of DgcB (Fig. 2d).
In total, our structures and the sequence conservation of the
DgcB tail suggest that this region is likely to be the true ligand for
the FHA domain.
A phosphopeptide complex validates the DgcB:tail interaction.
We sought to validate the in-cis FHA:tail interaction (a “basal”
unphosphorylated state) via obtaining a structure of the (likely
more relevant) phosphopeptide complex. By combining a tailless
DgcB FHA construct (residues 32–131, V32 replaced with an
initiating methionine) and synthetic phosphopeptide
(N7SDNLEKpTSIVASDT17) in-trans, we were able to obtain
complex crystals diffracting to 1.48 Å resolution. The asymmetric
unit of this new form contained two FHA domains that were in
an offset dimer identical to both the full-length and FHA-only
structures, providing a third independent observation of this
interaction. The exposed FHA cleft of chain B displays clear
density for a bound phosphopeptide, allowing unequivocal
modeling of residues 11–21 (Fig. 3a–c). The conformation of the
bound tail region does not differ substantially from that of the
unphosphorylated complex (rmsd 1.0 Å for all atoms), but sits
relatively deeper into the FHA cleft, making more extensive
contacts (Fig. 3d). The more deeply situated tail is now able to
form mainchain hydrogen bonds with R61, K72 and N97 (via
both groups of the amide sidechain). The extended conformation
of the tail (~30 Å across) results in the sidechains of E12, K13, I16
and S19 facing away from the FHA domain. The FHA surface
creates two depressions which accommodate the two “inwardly
projected” residues of the tail (pT14 and +3 V17, Fig. 3b); the
ﬂanking L11 and T21 sidechains sandwich opposing sides of the
central FHA body. The C-terminal end of the tail packs against
the preceding residues, with the sidechain of T21 making a
hydrogen bond to the carbonyl of A18. The central pT14 of the
peptide tail is recognized by a multitude of interactions, the
sidechain methyl group projecting into a pocket formed by
a b
c
d
GGDEF (A)
c-di-GMP
I-sites
GGDEF (B)
FHA (B)
*
*
*
*
*
*
FHA (A)
E229
E230
F231
D221
R218
T96
D56′
S75
R76
R76′
S75′
T96′
V174
I126
L175
I40
P43
P42
R171′
L175′
V174′
Y45
K48 D70
Y68
E167′
R76′
R76
Fig. 1 Structure of full-length B. bacteriovorus DgcB (I site RxxD motif colored orange, active site GGEEF sequence green), with bound c-di-GMP located at
interface of the two chains (A white, B tan, residue numbers in chain B given as prime). Residues in the FHA domain binding cleft are colored purple.
a Juxtaposition of asymmetric FHA domains and GGDEF dimer, end of traceable regions denoted by sphere and asterisk symbol. b View 90˚ to that of
a, demonstrating c-di-GMP intercalation at I-site of GGDEF dimer, holding the two active sites (green) antipodal to one another. c View from beneath
GGDEF interface, showing FHA:FHA interaction and the projection of D56 (cyan) from chain B into the chain A FHA binding cleft. The two FHA domains
are related by a ~90˚ rotation. d The chain A FHA domain is sandwiched by both protomers of the GGDEF dimer, particularly the helical turn residues V174
and L175 (colored yellow)
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residues 72–75 and 96–97, which positions the phosphate toward
the positively charged R61 and R76 (Fig. 3). The phosphoryl
group is tightly co-ordinated by the FHA cleft of DgcB: OG by
R61, O1 by S95 and T96, O2 by both the backbone NH and
sidechain of R76, and O3 by R76 (and the backbone NH of pT14
also). Comparison of the peptide-bound and unbound FHA
domain structures reveals that peptide binding does not induce
any obvious gross conformational change or long-range signaling
motions, merely alterations in the rotameric states of R61, K72
and R76 (Fig. 3d). These alterations do not seemingly propagate
any further change in the molecule distant from the recognition
cleft (Supplementary Fig. 1).
Design of a constitutively active mutant protein. Our structure
of the phosphopeptide tail:FHA complex was suggestive of a
model wherein phosphorylation of the DgcB tail could activate
the C-terminal GGDEF domain toward producing c-di-GMP
(with the above observations suggesting that activation would
arise via domain rearrangement). To test this hypothesis, in the
context of not having identiﬁed the Bdellovibrio kinase that could
speciﬁcally phosphorylate the tail, we aimed to use our structure
to design a mutant with an enhanced propensity to adopt the tail-
bound conformation. Initially we attempted a phosphomimetic
mutant: activity assays with a T14D-R218A variant (the latter
substitution preventing feedback inhibition at the I site) gave only
a very small increase in diguanylate cyclase activity c.f. wild-type
protein (Fig. 4), in agreement with the general literature view that
acidic substitutions are not good analogues of phosphothreonine.
We therefore sought to identify residues that would tolerate
disulphide linkage between the tail and body of the FHA domain
(one cysteine substitution on each, adjacent to one another),
giving a covalent “trapping” under oxidizing conditions. Initial
analyses with Disulﬁde-by-design software18 were negative but
manual inspection of the structure revealed a region of the fold
that could be amenable to modiﬁcation if given a simple
a b
c
d
D56
T96 D56
T96
S19
T96
K13
D56
T96
D56
S19
A18
I16
V17
S15
K13
N97
T14
T96
R61
S75
S19 K13
T14
D21′
pT15′
M1′
A44′
V32
Variable  –1
Charged  –2
Hydrophobic  –3
+1  Semi-conserved
+2  Hydrophobic
+3  Hydrophobic
odhI
GarA
HD100
B. exovorus
Strain W
ArHS
H. marinus SJ
MXAN5199
MXAN1525
MXAN4029
R76
Fig. 2 Structure and analysis of a DgcB tail-FHA construct lacking the GGDEF domain. a The asymmetric unit of this form contains four FHA domains,
arranged at ~90˚ to each other, with each replicating the D56-mediated FHA:FHA interactions of the full-length structure (via symmetry mates at edge of
tetramer, not shown in ﬁgure). One of the four tail regions is ordered (peptide K13-S19, colored yellow) binding across the recognition cleft of a FHA
domain, suggestive that the DgcB peptide ligand is derived from self. b) Sequence alignment of N-terminal tails of known self-interacting FHA domains
(Mycobacterial GarA and OdhI) with DgcB and selected homologues (DgcB equivalents from ﬁve Bdellovibrio strains and three similar M. xanthus FHA:
GGDEF proteins). The properties of six positions (−3 to +3) ﬂanking the central Thr of the binding motif are annotated. c Interaction between the DgcB tail
peptide and FHA domain, hydrogen bonds shown as green dashed lines. Peptide recognition is driven by two groupings of residues that line a cleft of the
FHA domain (near grouping colored pink, far grouping purple; cleft is easily discerned in a where both groups are colored purple). d Structural overlay of
DgcB FHA:tail complex (FHA tan, tail yellow) with that of OdhI (blue, PDB code 2KB3, residue numbers denoted by prime). The peptide ligands of both
DgcB and OdhI bind in a similarly extended conformation, with DgcB T14 and OdhI pT15’ projecting into a conserved pocket on their respective FHA
domain receptors
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rotameric alteration from its observed conformation. The S15
residue immediately after pT14 faces toward a loop present on the
FHA β-sandwich that contains S73 (Fig. 4a). In all three of our
DgcB structures, the OG of S73 hydrogen bonds to the backbone
NH of N124 and sidechain of D71; but manual alteration to a
different rotamer would position it towards S15 of the tail. The
resulting 2.9 Å distance is longer than the S:S distance in a dis-
ulﬁde, but an S to C substitution at both partners would be
isosteric and able to partially ﬂex/move to shorten this gap.
Production of c-di-GMP was monitored by both HPLC
analyses and a circular dichroism assay system (modiﬁed
procedures based on original protocols by Stelitano et al.19),
alongside the well-characterized YdeH (DgcZ) GGDEF enzyme as
a positive control20. The R218A mutation at the I-site was
engineered into constructs to relieve auto-inhibition and max-
imize c-di-GMP detection, and a negative control provided via
GGDEF catalytic site mutation (E229A, E230A). A basal signal of
c-di-GMP was observed in the wild-type enzyme, as a result of
co-puriﬁcation with c-di-GMP (as demonstrated in our full-
length structure). Analyses of mutant proteins combining these
variations revealed strong activity for only the S15C-S73C-R218A
enzyme (Fig. 4b–h), the reaction going to completion ~45 s after
GTP addition (at 10 µM protein). In contrast, a single cysteine
mutant (S15C-R218A—used to control for the potential effect of
cys bringing GGDEFs together in non-speciﬁc fashion) displayed
no signiﬁcant activity (Fig. 4c, d, f). We conclude that the above
design procedure is valid, and that activation is a speciﬁc
consequence of FHA cleft occupancy, with the mutant acting as a
proxy for phosphorylation. The observation of strong activity for
our “disulphide-stapled” mutant led us to investigate whether we
could speciﬁcally reverse this effect via TCEP-mediated reduction.
The CD spectrum shows that post reduction, the double cysteine
mutant is still folded (Fig. 4g), and c-di-GMP production is not
detectable even at 10 µM protein (Fig. 4h). Taken together, these
results demonstrate inducible control of DgcB activity, and
further validate our peptide complex structures. Other control
experiments conﬁrm that the I-site is not masking wild-type
activity (the single R218A mutant is not active), and that removal
of the FHA domain is not sufﬁcient to activate DgcB (the
GGDEF-only construct puriﬁes with a small amount of c-di-GMP
at the I-site, but does not display signiﬁcant activity, as
ascertained by analysis of the GGDEF-only R218A protein).
Relation of DgcB oligomeric state to activity. Stimulated by the
observation that DgcB S15C-S73C-R218A licensed cyclic-di-
GMP production, we next sought to understand the relationship
between DgcB oligomerisation and activity (Fig. 5). Initial size-
exclusion chromatography conﬁrmed our structural observation
that cyclic-di-GMP holds DgcB in a dimeric state, which converts
to a monomer with the R218A substitution (Fig. 5a). In a separate
control, the S15C-S73C-R218A variant remains monomeric
under reducing conditions (Fig. 5b), but converts to a more
complex ensemble when oxidized, which we assigned to ﬁve
major fractions (Fig. 5c). Calibration to known standards, and
validation by non-reducing SDS-PAGE (Fig. 5d), indicate these
sizes to be aggregate (peak 1), higher-order oligomer (peak 2),
tetramer (peak 3), dimer (peak 4) and monomer (peak 5). The
denaturing, non-reducing conditions of the SDS-PAGE indicate
that the dimer is almost exclusively disulphide-linked between
chains (tail to FHA of opposing subunits) rather than within
chains. Assuming that the individual peaks don’t interconvert, we
assayed these separate fractions for activity, inclusive of controls
for total oxidized (all size fractions included) and total reduced
protein. Intriguingly, differently sized-oligomers of DgcB all dis-
played differing activity proﬁles (Fig. 5e). The reduced and oxi-
dized controls conﬁrmed the earlier ﬁnding that the DgcB
S15C-S73C-R218A variant could be activated via oxidation. As
expected, the non-speciﬁc aggregate fraction displayed the least
activity of the oxidized samples (peak 1). The dimer (peak 4) was
the most active state, displaying faster consumption of GTP than
the total oxidized protein (mixed, all oligomers). Monomers,
tetramers and other oligomers were all active, but to a lesser
degree than the enriched dimeric fraction.
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Discussion
We have structurally determined several states of the Bdellovibrio
diguanylate cyclase DgcB, allowing us to document the
mechanisms behind both inhibition and activation of c-di-GMP
production. The full-length form of DgcB is informative of reg-
ulation, providing information on several domain interfaces
(FHA:FHA, FHA:GGDEF and GGDEF:GGDEF). The con-
formation we observe likely represents a feedback-inhibited state
wherein the GGDEF domain has been locked by the c-di-GMP
product into a non-productive conformation; we posit that this
represents a form present after entry of prey. This state is further
stabilized/inhibited by protein:protein interactions—the FHA
domains making contacts to one another, and also the GGDEF
domains (in particular chain A situated between the two α0
helices). DgcB binds c-di-GMP using both I-sites of the GGDEF
dimer, forming a pseudosymmetric protein:nucleotide complex.
This mode of inhibition is distinct from most well-characterized
GGDEF proteins, which usually complex c-di-GMP via a single I-
site in conjuction with another region of the fold (e.g. the REC
domain of PleD12). To the best of our knowledge, this two-fold
arrangement has only been observed in the Dcsbis GGDEF from
P. aeruginosa21 where the enzymatic domain is appended to a
differing GAF sensory domain. This observation is related to the
asymmetric orientation of the stimulus-sensing FHA domains,
i.e., a symmetric GGDEF dimer centred around the I-site con-
stricts the space available at the N-terminal end of the fold.
Hence, most GGDEF proteins do not adopt this orientation as it
would lead to steric clashes of the appended sensory domains, but
in DgcB this conformation is enabled by having the chain B FHA
domain offset. Supportive of this idea is the ﬁnding that the I-site
symmetrical dimer of Dcsbis was obtained from a truncated
construct (lacking the sensory GAF domain), and that the full-
length protein adopts a different conformation.
FHA asymmetric intercalation into the GGDEF dimer appears
to be relevant because the hydrophobic residues involved are
conserved in DgcB homologues, and both the FHA:FHA and
GGDEF:GGDEF orientations compatible with this arrangement
have been observed independently in multiple structures (FHA
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Fig. 4 Design, validation and regulation of a disulphide-activated DgcB mutant. a Design of the disulﬁde mutation to lock DgcB into a constitutively active
state. S15 and S73 were identiﬁed as the best candidates for mutation to cysteine residues as to facilitate the formation of a disulphide bond (a different
rotamer for S73, labeled with prime, would be in an appropriate orientation to bond S15 when both mutated to Cys). b Circular dichroism assay with 10 µM
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monitoring c-di-GMP production at 10 µM protein. Bars ± standard deviation. Signiﬁcance between samples with and without GTP calculated by Student’s
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the three separate forms of this study, GGDEF homologues in
other studies1). Asymmetry can be a powerful means of reg-
ulating signaling networks, e.g. as observed in the ChpT-CtrA
phosphorelay of Brucella abortus17. Like other GGDEFs, I-site
inhibition of DgcB is dominant over the active state, as shown by
our activity assays (Fig. 4). Physiologically, this mechanism exists
to set an upper limit for local [c-di-GMP] at the prey-interacting
pole of the B. bacteriovorus cell, which from DgcB production
would persist over a very speciﬁc (relatively short) timeframe
during prey invasion8.
The orientation of the GGDEF domains in an active enzyme is
presumed to be 180˚ from that of the I-site inhibited form—this
productive state would allow the GG(D/E)EF motifs (of a dif-
ferent dimeric arrangement) to approach one another, leading to
two molecules of GTP positioned correctly to form the cyclic
product. It is important to consider the DgcB structure in the
context of general features of GGDEF activation - almost without
exception, GGDEF proteins with differing stimulus-sensing/input
domains (Rec, PAS, GAF, HAMP, transmembrane, usually N-
terminal to the enzymatic domain) use a helical coiled-coil (α-1)
to communicate the regulatory signal22. When comparing ﬁve
well-characterized GGDEFs, this region demonstrates relative
ﬂexation, leading to a generalized model that uses the tilt angle
between α-1 and the catalytic domain to modulate the frequency
of GGDEF:GGDEF encounter and thus c-di-GMP formation22.
The tilt/communication may be regulated by two continuous
features – a heptad repeat region of the coiled coil, and a con-
sensus DxLTxxxN/SR/K motif that forms a wide β-turn that leads
into the GGDEF fold. The differing conformation of the
D150xLTxxxSK158 regions in DgcB is of interest—chain B places
this motif in the consensus β-turn conformation found in the
majority of GGDEF structures. In contrast, the DxLT component
of chain A forms part of a helix in the interdomain linker,
unwinding the region afterward such that S157 projects toward
D221 of the I-site RxxD motif. There is no suggestion that this
unusual conformation of the chain A DxLT motif is mechan-
istically relevant—the small helix (aa 147–154) would be per-
ipherally located/isolated in a GGDEF dimer where the active
sites were productively engaged. However, the plastic nature of
this region in general is of interest given the aforementioned tilt
model of activation and requirement for multiple conformations;
our structures suggest that the arrangement of the DxLT motif
can alter into a stable form, rather than an order/disorder
transition.
A substrate complex representative of a competent catalytic
state has yet to be obtained for a GGDEF enzyme, the closest
matches being a post-catalysis form of YdeH/DgcZ23 (with c-di-
GMP product spanning two active sites), a complex of IsPadC
(GTP locking the monomers together rather than juxtaposing
active sites)24 and an active/empty IsPadC heterodimer with
quasi-translated coiled coils25. GGDEF activation can be triggered
by stimulus-induced dimerization (e.g. PleD12) and/or stimulus-
induced domain rearrangement (often relieving self-inhibitory
interactions, e.g. DosC26). The observation of the DgcB FHA
sensory domain in a common dimeric conformation across our
three separate structure determinations suggests that this complex
is stable (as a constitutive dimer, even in the absence of the
GGDEF domain), and would need at least partial rearrangement
to place the GGDEF domains into an active conformation.
The orientation of the DgcB FHA domains in a form lacking c-
di-GMP inhibition remains enigmatic, and we were unsuccessful
despite extensive trials with a R218A mutant; if the FHA domains
kept the same interaction as the three structures presented herein,
one FHA phosphopeptide cleft would be exposed and the other
sequestered (via R61 of the “closed” monomer binding to E64 of
the “open” monomer, and D56 inserting into the “closed” site
near to where the phosphothreonine binds). Our structure of the
FHA:phosphopeptide complex demonstrates that cleft occupancy
does not alter the FHA:FHA contacts, at least for a peptide added
in trans. Hence, rearrangement will presumably require cis
phosphopeptide binding, wherein the two elements that ﬂank the
pThr epitope (aa 1–10, 22–31) can alter the surface properties of
the FHA domain and change the domain:domain packing; tail-
binding could promote new interactions (e.g. in the inter-domain
linker region) and/or relieve inhibitory interactions (e.g. our
observed FHA:GGDEF interface). Our observation that both the
unphosphorylated tail (intrinsic) and phosphorylated form
(extrinsic) can bind the DgcB FHA domain is in keeping with
other (non-GGDEF) FHA proteins, e.g. GarA15, and the mode of
peptide binding is similar despite the pronounced differences in
FHA sequence and functional usage. Our activity assays
demonstrate that this “non-speciﬁc” binding does not appear to
result in any signiﬁcant c-di-GMP production (Fig. 4b, e), pre-
sumably providing tight control on the process of prey invasion.
We can conclude that the I-site c-di-GMP is self-produced,
because the E229-E230 variant does not co-purify with nucleotide
(Fig. 4e); so the small amount of wild-type basal activity is enough
to eventually saturate the protein over the longer timescale of
recombinant production.
From careful searching of the literature, we are not aware of
any other covalently-locked FHA variants; this methodology may
thus be of interest as a tool to study other signaling systems. The
vastly increased c-di-GMP production of the S15C-S73C-R218A
mutant of DgcB can be interpreted (as intended from design
guided by the phosphopeptide complex) as a locked active form
that has lost I-site inhibition. Historically, it has been easier to
design obligate “off” GGDEF proteins versus obligate “on” var-
iants, with a notable exception being a GCN4 zipper:GGDEF
fusion protein with high activity that dimerizes around an
introduced strong coiled-coil forming segment27. The differences
between wild-type DgcB (no appreciable activity), T14D-R218A
(phosphomimetic, minor c-di-GMP production) and S15C-S73C-
R218A (presumed locked tail, strong activity) are very suggestive
of DgcB activation via FHA tail phosphorylation. This hypothesis
is strongly supported by the ability to reverse the activation of the
S15C-S73C-R218A form using TCEP to reduce the disulﬁde
between the tail and FHA domain (Fig. 4g).
There are several potential modes in which tail-driven reor-
ganization of the observed asymmetric FHA:FHA interface could
occur, all of which have been observed to operate for different
FHA-containing proteins: formation of intradomain contacts (tail
binding self, akin to GarA15, OdhI28) or interdomain contacts
(tail binding oligomeric partner, head-to-head, head-to-tail, or as
a ﬁbre akin to TIFA29). Head-to-tail and ﬁbre models would
require an active form larger than a dimer to place the GGDEF
domains together. Our dissection of the differing activities for
different oligomeric states of DgcB (Fig. 5) suggest that although
monomers, tetramers and higher-order oligomers all demonstrate
some activity, the most-highly active species was the dimeric
form. We are able to combine intra- and head-to-head inter-
domain models with both our observed structures and general
principles for GGDEF activation into a working model for the
DgcB active state (Fig. 6). There is some evidence from our
reducing SDS-PAGE that the inter- linked conformation (tail into
opposing monomer) may be more prevelant in the active dimers
(Fig. 4d). Herein we have used constraints from a dimeric
pseudoactive IsPadC structure (5LLW24) to position two copies of
chain B from full-length DgcB. The resultant orientation is
sterically compatible with both FHA domains and bound phos-
phopeptide tails (superimposed), leaving the linker peptide
appropriately positioned to span the region occupied by the
IsPadC coiled coil. Adoption of this state would require both the
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linker (aa 135–143) and start of wide turn (aa 144–148) to adopt a
helical conformation (~2 heptad repeats), which is interesting
given our observation of a small helix preceding the turn in chain
A of the full-length DgcB. The distances involved are similar for
either intra- or inter- FHA:tail interactions. For the purposes of
tail-binding driving conversion into the active state, this model
suggests that the two ﬂanking regions (either side of the tail)
could assist by orienting away from the coiled coil space (aa
22–31) and possibly contacting the GGDEF domains (aa 1–10).
Tail-binding would also occupy the FHA cleft, relieving the FHA:
FHA contacts observed in all three of the structures presented
here. Further, our model uses a 1:1 stoichiometry of tail:FHA, as
we believe the 1:2 ratio of our phosphopeptide complex structure
to be related to crystallization conditions. Lastly, the FHA:
GGDEF contacts observed in our full-length structure are
incompatible with an occupied FHA cleft, suggesting that part of
DgcB activation could result from GGDEF “release” from this
state and associated increase in conformational freedom.
Our conﬁrmation herein of phosphopeptide-gating of DgcB
activity, ultimately licensing Bdellovibrio local cyclic-di-GMP
production and therefore predation, requires context regarding
upstream and downstream signaling events. The kinase respon-
sible for phosphorylating DgcB T14 has not been identiﬁed (and
this is beyond the scope of this study), but presumably senses
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red) is re-oriented in main panel to demonstrate that the active state model in b is derived from chain B of our experimentally determined full-length
structure. Lower panel, near-active GGDEF dimer of IsPadC (PDB 5LLW, sensory domains removed, individual chains yellow and green), displaying a
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productive association of the GGDEF active sites (dark green) and synthesis of c-di-GMP. The resultant c-di-GMP signals downstream invasion processes
until an upper threshold is achieved and DgcB subsequently inhibited via I-site mediated feedback (I-site, orange block; as observed in our full-length
structure). The Bdellovibrio bacteriovorus lifecycle stages corresponding to these events are represented below (predator orange, prey dark brown)
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prey encounter and has multiple protein substrates. Our working
hypothesis is that the kinase would sense a stimulus upon prey
encounter (Myxococci sense osmolarity changes when exposed to
prey30), and become active, phosphorylating T14 of DgcB to
stimulate conformational change into a state capable of produ-
cing cyclic-di-GMP. Supporting this hypothesis, the distantly
related predator Sorangium cellulosum encodes for a putative
974aa fused kinase-tail-FHA-GGDEF protein (UniProt
BE21_29150), whose kinase domain is most similar to Bdellovi-
brio gene product Bd3148 (26% identity; interestingly this also
shares 27% identity with the PknG kinase that phosphorylates the
OdhI FHA tail31). Intriguingly, Bd3148 is most-highly expressed
during attack phase when Bdellovibrio is ready to initiate preda-
tion32 and has been identiﬁed as compromising predation when
interrupted by transposon insertion33. The dominance of I-site
inhibition questions whether a phosphatase is needed to limit
DgcB activity, but in support of such a hypothesis, a putative
phosphatase exists in the same operon as dgcb/bd0742 (bd0740,
PFAM PF10049 calcineurin-like family). Downstream of DgcB
activation, CdgA (Bd3125) is a c-di-GMP receptor with an
invasion-related phenotype, organizing processes at the “biting”
pole of Bdellovibrio8; the stronger phenotype of ΔDgcB over
ΔCdgA is suggestive of more than one target for DgcB-produced
c-di-GMP.
Our investigations have provided the ﬁrst details behind the
mechanisms used to activate DgcB function, and thus signal prey
invasion in the bacterial predator Bdellovibrio bacteriovorus. We
provide the molecular basis for initiation of c-di-GMP produc-
tion, demonstrating that the stimulus is a phosphopeptide tail
present on the DgcB GGDEF synthase itself. Our model allows
the design of a sensor-locked, obligate “on” variant, whose
activity is validated by in-vitro assays; this mode of distant sti-
mulation mimics the natural stimulus (phosphopeptide occu-
pancy) and is distinct from other studies that alter the GGDEF
coiled coil region directly to achieve activation24,27. These
observations provide a starting point for exploring the signaling
network that underpins entry into the staged lifecycle of this
bacterial predator and further enrich our general understanding
of GGDEF activation/regulation.
Methods
Cloning. [NB the original HD100 gene annotation for DgcB has the start sequence
misannotated, mature protein starting at M11AHN of UNIPROT entry Q6MPU8.
Throughout this manuscript the DgcB numbering follows our start site annota-
tion.] Primer sequences are provided in Supplementary Table 1. Full-length (aa
1–310), GGDEF domain only (aa 148–310), FHA domain with N-terminal tail (aa
1–135), and FHA domain only (aa 33–135) constructs of dgcB were ampliﬁed from
B. bacteriovorus HD100 genomic DNA. The ampliﬁed genes were inserted into a
modiﬁed pET41 expression plasmid (Novagen, thrombin cleavable 8xHis-tag
introduced at C-terminus, and GST-tag removed) by restriction-free cloning.
Mutant variants (T14D, S15C, S73C, R218A, E229A, and E230A) of DgcB con-
structs were produced by standard site-directed mutagenesis. Constructs were
conﬁrmed by sequencing, and introduced into the E. coli expression strain
BL21λDE3 (New England Biolabs). A pET28a plasmid encoding ydeH (kindly
provided by the Schirmer laboratory, constructed by Dr. Alexander Böehm, Bio-
zentrum Basel) was transformed into BL21λDE3.
Protein production and puriﬁcation. Cells containing DgcB constructs were
grown at 37 °C (shaking incubation at 180 RPM) in 2× LB supplemented with
100 µg/ml kanamycin until an OD600 of 0.6–1 was reached. Gene expression was
then induced with 0.5 mM IPTG and cultures were grown overnight at 15 °C. Cells
were harvested by centrifugation at 6675 × g for 6 min and frozen at −20 °C (media
supernatant discarded). Cells were resuspended in buffer A (20 mM imidazole pH
7.0, 400 mM NaCl, and 0.05% v/v Tween 20) and lysozyme by gentle shaking at
10 °C. Cells were lysed on ice by sonication and centrifuged at 48,400 × g (4 °C) for
1 h to clarify lysate. The supernatant was then loaded onto HisTrap FF nickel
columns (GE Healthcare) pre-equilibrated in buffer A. Columns were washed with
12 column volumes of buffer A. Two 20ml elution steps at 8% buffer B (400 mM
imidazole pH 7.0, 400 mM NaCl and 0.05% v/v Tween 20) in buffer A and 100 %
buffer B were used to elute protein from the column. The protein eluate was
dialyzed overnight at 4 °C. Proteins were concentrated by Vivaspin® spin-
concentrators (Sartorius) and purity conﬁrmed by SDS-PAGE. For the RP-HPLC
and CD assays, proteins were dialyzed into 20 mM HEPES pH 7.0 and 200 mM
NaCl. For crystallization, ﬁnal dialysis buffers were composed of - wild type full-
length DgcB: 20 mM HEPES, 200 mM NaCl and 2 mM β-mercaptoethanol; FHA
domain N-terminal tail construct: 25 mM Na citrate pH 5.0, 100 mM NaCl and
10 mM HEPES pH 7.0; FHA only construct: 20 mM HEPES pH 7.0 and
200 mM NaCl.
BL21λDE3 with the YdeH construct was grown at 37 °C (shaking incubation at
180 RPM) in AI media (total volume 1 litre in dH2O: 10 g tryptone, 5 g yeast
extract, 3.55 g Na2PO4, 3.4 g KH2PO4 and 2.68 g NH4Cl, 2.5 ml of trace metals,
0.1 g glucose, 0.4 g lactose, 1 ml glycerol and 2 mM MgSO4). At an OD600 of 0.6–1,
cells were transferred to a 15 °C shaking incubator for O/N expression. Cells were
harvested by centrifugation at 6675 × g for 6 min. YdeH was puriﬁed from a
method adapted from that published previously20. Cells were lysed by sonication in
buffer C (50 mM NaH2PO4 pH 7.5, 200 mM NaCl, 10 mM imidazole, 50 mM
L-glutamic acid and 50 mM L-arginine) and lysozyme before clariﬁcation (as
performed for the DgcB constructs). Lysate was loaded onto HisTrap FF nickel
columns (GE Healthcare) pre-equilibrated in buffer C and eluted with a stepwise
gradient of buffer C supplemented with imidazole (up to 400 mM). Fractions were
dialyzed into buffer D (20 mM TRIS pH 7.6, 150 mM NaCl, 50 mM L-glutamic acid
and 50 mM L-arginine) overnight at 4 °C. Purity was conﬁrmed by SDS-PAGE.
Reducing size-exclusion chromatography for assay samples. DgcB variants
(WT, FHA, R218A, S15C-S73C-R218A) were puriﬁed by nickel afﬁnity chroma-
tography as described above and then dialysed into reducing gel-ﬁltration buffer
(20 mM tri-sodium citrate, pH 6.5; 250 mM NaCl; 2 mM DTT) prior to con-
centration by ultraﬁltration to 50–80 mg/ml. Proteins were then subject to gel-
ﬁltration on a Superdex 200 26/60 column (GE Healthcare) equilibrated in the
dialysis buffer.
Non-reducing chromatography & SDS-PAGE of oxidized samples. For analysis
of disulﬁde-induced protein oligomerisation, DgcB S15C-S73C-R218A protein was
prepared by gel-ﬁltration as described above and then fractions of pure protein
were pooled, concentrated to 10 mg/ml and dialysed extensively against gel-
ﬁltration buffer lacking DTT (non-reducing gel-ﬁltration buffer). Protein was then
supplemented with 5 mM oxidised glutathione and incubated overnight with gentle
agitation. This sample was further concentrated to 50 mg/ml before being subject to
further gel-ﬁltration with non-reducing gel-ﬁltration buffer. Fractions of eluted
protein were collected and analysed by non-reducing SDS-PAGE to assess disulﬁde
induced cross-linking. The elution proﬁle of DgcB S15C-S73C-R218A under non-
reducing conditions and the non-reducing SDS-PAGE gel were used to subdivide
the elution proﬁle into ﬁve distinct peaks, which were then concentrated to
>10 mg/ml for use in CD assays.
Structure determination. Crystals were grown at 18 °C using the sitting drop
technique. For the FHA domain:phosphopeptide complex (aa 33–135), protein was
mixed at a 1:1 stoichiometry with a C-terminally amidated phosphopeptide with
the amino acid sequence NSDNLEK(p)TSIVASDT (where (p)T is a phosphory-
lated Thr residue). Crystals were obtained in 0.2 M K bromide, 0.1 M Na acetate
pH 5.5 and 15% w/v polyethylene glycol (PEG) 4000 (for aa 1–310, 40 mg/ml
protein); 0.2 M ammonium formate, 10% w/v polyvinylpyrrolidone and 20 % w/v
PEG 8000 (for aa 1–135; 5 mg/ml protein), and 0.1 M Na-HEPES pH 7.0 and 20 %
w/v PEG 8000 (for aa 33–135, 5 mg/ml protein). Crystals were cryoprotected in
mother liquor supplemented with 20 % (v/v) ethylene glycol before being ﬂash
cooled in liquid nitrogen. Diffraction data were collected at the Diamond Light
Source in Oxford, UK. Data reduction and processing was completed using
iMosﬂm34 (aa 1–310) or the xia2 suite35 (aa 1–310; aa 33–135). Molecular repla-
cement of the full length structure (aa 1–310) used both FHA and GGDEF search
model ensembles of PDB codes 3IGN, 3TVK, 2WB4, 3I5B, 3ICL, 4QCJ, 2XT9,
3OUN, and 3PO8 via PHASER36. A clear solution was obtained with two copies of
DgcB in the asymmetric unit. The FHA domain of the reﬁned full length structure
was used to solve both the aa 1–310 form (Four copies in the AU) and aa 33–135
form (two copies in AU). Protein structures were built/modiﬁed using COOT37,
with cycles of reﬁnement in PHENIX38 and PDB-REDO39.
Reverse phase high-performance liquid chromatography assay. Two reaction
mixes (total volume in each, 100 µl) composed of 10 µM protein, 20 mM HEPES
pH 7.0. 200 mM NaCl and 10 mM MgCl2 (with one of the reaction mixes con-
taining 100 µM GTP) were set up for each protein assayed. To compare the single
to the double cysteine mutant 1 µM of protein was used. Reaction mixes were
incubated at 24 °C for 40 min. The reaction was heat inactivated at 98 °C for
10 min. Samples were clariﬁed by centrifugation at 13,000 RPM for 15 min in a
benchtop centrifuge. The supernatant was centrifuged for an additional 20 min at
13,000 RPM before being gently transferred into HPLC micro-sampling vials.
Samples (4 µl) were analyzed on a kinetex 1.7 µm (particle size) C18 100 Å (pore
size), 150 × 2.1 mm column connected to a Dionex Ultimate3000 UHPLC system
with a detection wavelength of 252 nm. The ﬂow rate was set at 0.1 ml/min. The
mobile phase was 100 mM Na phosphate pH 5.8/methanol (95/5, v/v). Three
technical repeats were undertaken for each protein sample.
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Circular dichroism assay. Reaction mixes (total volume 3ml) consisting of 10 µM
protein, 200 mM NaCl, 20 mM HEPES pH 7.0 and 10 mM MgCl2 were set up in a
1 cm pathlength quartz cuvette (For YdeH, buffer D supplemented with 10 mM
MgCl2 was used). For size excluded samples a modiﬁed buffer of 20 mM tri-sodium
citrate, pH 6.5, 250 mM NaCl, and 10 mM MgCl2 was used to prevent aggregation
of the mutant protein. Additionally, the single and double cysteine mutants were
monitored at a protein concentration of 1 µM. Circular dichroism (CD) mea-
surements were taken in a Jasco J-1500 instrument with a PTC-517 accessory at a
constant 25 °C. Sample was continuously mixed within the cuvette by a magnetic
stirrer set at 100 RPM. The CD detection wavelength was set at 282 nm. Reaction
was initiated by GTP (at a ﬁnal concentration of 100 µM) and monitored every
second. A total of three technical repeats were performed for each protein sample.
The effect of reduction was tested by overnight incubation of the double cysteine
mutant (speciﬁcally S15C-S73C-R218A) in reaction buffer supplemented with
12.5 mM TCEP. To conﬁrm retention of ordered structure, this sample was diluted
1 in 100 in dH2O and a regular CD spectrum was taken from 195 to 250 nm.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
Coordinates and structure factors have been deposited in the PDB under accession codes
6HBZ for the full-length protein, 6HC0 for the FHA-only structure, and 6HC1 for the
FHA:phosphopeptide complex. The source data underlying Figs. 4 and 5 are provided as
a Source Data ﬁle. Other data are available from the corresponding author upon
reasonable request.
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